samedan logo
 
 
spacer
home > pmps > autumn 2019 > preparing for change
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Preparing for Change




The pharmaceutical packaging industry has evolved significantly in recent years as new technologies and pioneering solutions have been developed to meet changing market requirements. Additionally, companies continue to explore ways to drive efficiencies across the supply chain, streamline their operations, and reduce time to market.

Serialisation

Over the last few years we have seen the implementation of serialisation regulations within the pharma industry, in response to the number of counterfeit products entering the supply chain. These new regulations that now exist in multiple markets aim to combat this issue by making drug products verifiable as they pass through the supply chain, ensuring greater safety for patients.

In February 2019, regulators implemented the EU Falsified Medicines Directive (FMD). The regulation introduced new requirements for manufacturers whereby they are now expected to ensure products are affixed with a unique serial number and barcode. This guarantees each product’s shelf life, batch number, and origin are traceable and that products can be verified as legitimate at the point of dispense to the patient.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Dexter Tjoa is Director of Corporate Strategy at Tjoapack. He is responsible for devising, implementing, and evaluating the mid to long-term strategies of the company and the services it offers, as well as overseeing the commercial, finance, and IT departments within Tjoapack. Dexter has been with the company for three years, during which time he launched Meditraq, one of Tjoapack’s sister brands, which offers contract serialisation services. He holds a BSc in Mathematics from the University of London, UK, and an MSc in Mathematics and Computer Science from the University of Oxford, UK, and has previously worked in the technology sector.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Emmes launches Orphan Reach™: Emmes’ Rare Disease Center

03rd November, 2021, Rockville, Maryland (USA): Emmes – a full service, global clinical research organization (CRO) – is launching its new center, Orphan Reach™ as a unique ‘rare CRO’.
More info >>

White Papers

Successfully managing the unique demands of cell therapy supply chains

PCI Pharma Services

Cell therapy professionals joined a specialist webinar by industry experts from PCI Clinical Services and TrakCel, addressing the unique complexity of an autologous therapy supply chain. Hosted by European Pharmaceutical Manufacturer magazine, the webinar was delivered by Rachel Griffiths, Associate Director, Technical Services, PCI Clinincal Services, and Dr. Matthew Lakelin, Vice President, Scientific Affairs and Business Development, TrakCel . Here, we present the white paper from that webinar event.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement